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Abstract 
Sulfated glycoprotein 2 (SGP-2) mRNA progressively increased in the ventral prostate of the aging rat, reaching, at 24 months, 4-fold higher than 
at 3 months. Omithine decarboxvlase (ODC) mRNA neaked at 6 months (4-fold increase), and at 12 and 24 months was maintained at higher levels 
than at 3 months. ODC enzymatic activity was enhanced at 6 months to amuch smaller extent han its own mRNA, the values at 12 and 24 months 
dropping to below those at 3 months. Putrescine (Put), spermidine (Spd) and sperrnine (Sp) concentrations also peaked at 6 months (100% increase 
for Put, 50% for Sp and Spd). At 24 months, Put and Spd were diminished, and Sp was unchanged with respect o the 3-month values. Under the 
same conditions, glyceraldehyde-3-phosphate dehydrogenase mRNA did not undergo significant alterations. 
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1. Introduction 
The progressive decline in physiological functions and 
resistance to diseases that characterizes the aging process 
appears to be related to a gradual relaxation in the con- 
trol of gene expression, resulting in a slow loss of cell 
differentiation. Previous studies have reported direct and 
indirect evidence of changes in the expression of specific 
genes during aging (reviewed in [l]). 
We have been investigating the possible cellular func- 
tions of sulfated glycoprotein 2 (SGP-2, clusterin) [2-71, 
a heterodimeric glycoprotein of approximately 80 kDa 
that has attracted the interest of many researchers be- 
cause of its broad distribution in animal tissues and body 
fluids and its involvement in a variety of biological proc- 
esses as diverse as programmed cell death, extracellular 
lipid transport, and complement cascade regulation (re- 
viewed in [8-121). 
Changes in the levels of SGP-2 transcript have been 
studied by us [3,5,6] in several systems in parallel with 
changes in the levels of the transcript for omithine decar- 
boxylase (EC 4.1.1.17; ODC). The latter is a regulatory 
enzyme that catalyzes the production of the diamine pu- 
trescine, a biosynthetic precursor of aliphatic polyam- 
ines, spermidine and spermine [13,14]. These are ubiqui- 
tously distributed endogenous polycations required for 
normal or pathological cell growth. In fact, ODC re- 
sponds typically, although not exclusively [HI, to trophic 
stimuli, with increases in the amount of enzyme mole- 
cules, often, but not always, in consequence to corre- 
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sponding enhancements in the amount of its mRNA 
[13,14]. -
We have reported previously that the dramatic aug- 
mentation of SGP-2 mRNA occurring in the ventral 
prostate of the rat following androgen depletion, is ac- 
companied by a marked diminution in ODC mRNA [6]. 
Similarly, in an another model of programmed cell 
death, rat thymocytes under the influence of glucocorti- 
coid, SGP-2 mRNA increases [3] while ODC mRNA 
decreases [16]. In contrast, in phytohaemagglutinin-stim- 
ulated human peripheral blood lymphocytes we detected 
a decrease in the SGP-2 transcript that was accompanied 
by an increase in ODC mRNA [5]. 
In view of the fact that the levels of androgens and 
their receptors may undergo changes during the aging 
process, we addressed the question of whether SGP-2, 
ODC gene expression, and other parameters related to 
polyamine metabolism, are affected by aging in the rat 
ventral prostate. 
2. Materials and methods 
2.1. Animals 
Male rats of the Wistar strain aged 3-24 months, from a commercial 
source, were used. They were kept under controlled temperature, hu- 
midity and lighting conditions (lights on at 08.00 h and lights off at 
20.00 h) and with free access to water and food. 
2.2. Molecular probes and hybridization conditions 
The cDNA coding for SGP-2 was cloned in pUCl3 [2]. The recombi- 
nant plasmid, called pSB28, was digested with EcoRI and StuI to 
release the 1513 bp cDNA insert containing the entire coding region for 
SGP-2 and 67 bp of the 5’ region and 112 bp of the 3’ region. After 
isolation by agarose gel electrophoresis and purification by Geneclean 
(Bio lOl), the 1513 bp fragment was labelled by the oligolabelling kit 
from Promega in the presence of [a-32P]dCTP to a specific radioactivity 
of about 2 x lo9 dpm/pg DNA. The cDNA coding for ODC was ob- 
tained by pODCEl0, kindly donated by Dr. van Kranen [17]. After 
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digestion of the plasmid with EcoRI and HindIII, a 950 bp cDNA 
coding for ODC was excised, purified and labelled as in the case of 
SGP-2. The 1.2 kb fragment coding for glyceraldehyde-3-phosphate 
dehvdrogenase (GAPDH) was obtained bv digestion of the nlasmid 
with Psti. It was then purified and labelleh as-before. Northern blot 
analysis was performed according to Maniatis et al. [18]. Total RNA 
(10 pg) was blotted on Hybond membranes from Amersham and 
crosslinked with UV light. The prehybridization and hybridization con- 
ditions were as described elsewhere [2]. Quantitation of the autoradi- 
ograms was obtained by densitometric scanning (LKB Ultrascan XL 
densitometer). 
2.3. RNA preparation 
RNA extraction was performed using the guanidinium thiocyanate 
method of Chirgwin et al. 1191. 
2.4. Enzyme assay 
ODC activity was determined by quantitating the release of ‘%02 
from [I-“‘Clomithine by the method of Janne and Williams-Ashman 
[20] with minor modifications. Aliquots (about 0.2 mg protein) of the 
high speed supematants of tissue homogenates were incubated at 37°C 
for 60 min with 50 mM Tris-HCI, pH 7.5, 40 PM pyridoxal-5’-phos- 
phate, 5.0 mM dithiothreitol, 160pM L-omithine, 0.5 &i nL-[l-‘4C]or- 
nithine (57 mCi/mmol) in a final volume of 0.125 ml. 
2.5. Determination ofpolyamines 
Polyamines were extracted from tissues with perchloric acid and 
assayed by HPLC with fluorescence detection after pre-column deriva- 
tization with dansyl chloride [21]. 
2.6. Determination of protein 
Protein concentrations were detected according to Lowry et al. [22]. 
3. Results 
We report here the changes in the abundance of SGP- 
2, ODC and GAPDH mRNAs and in ODC activity and 
polyamine concentrations, occurring in the ventral pros- 
tate of the rat at 3, 6, 12 and 24 months of age. Fig. 1 
shows that in this organ the aging process is accompa- 
nied by a progressive marked increase in the levels of the 
mRNA for SGP-2 as detected by Northern blot analysis 
of total RNA. Indeed, accumulation of this transcript 
increased almost linearly, by 4-fold, in animals aging 
from 3 to 24 months. Under the same circumstances the 
mRNA for ODC increased by about 4-fold, from 3 to 6 
months, and decreased thereafter, although remaining 
higher than at 3 months (Fig. 1). Similarly to other rat 
tissues, Northern analysis of rat ventral prostate total 
RNA with rat ODC cDNA gave rise to three hybridiza- 
tion bands corresponding to three ODC mRNA species; 
since each single band appeared to be similarly affected 
by aging (Fig. 1) the three bands were quantitated to- 
gether. 
The transcript for GAPDH did not change signifi- 
cantly in the ventral prostate of the aging rat (Fig. 1). 
The activity of ODC determined in the same tissues 
(Fig. 2) exhibited a pattern similar to that of ODC 
mRNA, except that the increase at 6 months was much 
smaller and the activity at 12 and 24 months descended 
well below that detected at 3 months. Also the patterns 
of concentrations of putrescine and polyamines paral- 
leled those of ODC mRNA and activity (Fig. 2). At 
3 6 12 
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Fig. 1. Northern blot analysis of total RNA (10 pug) from rat ventral 
prostate extracted at the ages indicated and hybridized to SGP-2 (o), 
ODC (0) or GAPDH (*) cDNAs. Autoradiograms were quantitated 
by densitometric scanning. Patterns of repercentage values (values at 
3 months = 100) from one single representative experiment out of three, 
are shown. The densitometric values of the bands of the three ODC 
mRNA species were pooled. 
6 months, putrescine increased by more than 100% and 
spermidine and spermine by more than 50%. At 12 
months all three amines had returned to the 3 month 
levels. At 24 months the concentration of spermine re- 
mained constant, while that of spermidine decreased 
slightly, and that of putrescine was about 40% less than 
at 12 months. 
4. Discussion 
Age-dependent alterations in the expression of specific 
genes, either due to stochastic events and/or to a geneti- 
cally determined program, appear to be part of the mech- 
anisms underlaying the aging process. We show here that 
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Fig. 2. ODC activity (-), putrescine (x), spermidine (w) and spermine 
(r) concentrations in the ventral prostate of aging rats. Patterns of 
percentage values (values at 3 months = 100) from one single represen- 
tative experiment out of three, are shown. At 3 months, ODC activity 
was 1.070 nmol ‘%02 released/mg protein/h; amine concentrations 
were: putrescine 237, spermidine 1,742, spermine 1,002 pmol/mg fresh 
tissue. 
in the rat ventral prostate (and not in the liver or testis; 
Marinelli et al. manuscript in preparation), the transcript 
for SGP-2 increases almost linearly with increasing age; 
under the same conditions, the pattern of ODC mRNA 
peaks at 6 months, while GAPDH mRNA remains es- 
sentially constant. In other experiments not shown here, 
accumulation of SGP-2 mRNA in the ventral prostate of 
21-month-old rats was 1 l-fold higher than in 6-month- 
old animals. 
The extent, specificity and regular progression of 
SGP-2 mRNA accumulation strongly suggest hat the 
SGP-2 gene participates in the genotypic alterations ac- 
companying aging of the rat ventral prostate. Due to its 
distribution in biological systems that play totally differ- 
ent roles in mammalian organisms, many different func- 
tions have been proposed for SGP-2. The enhancements 
in the rate of its expression that often precede the phe- 
nomenon of programmed cell death (apoptosis), have 
provoked suggestions that SGP-2 plays a role in the 
latter process (reviewed in [8,9,11,12]). 
The age-related increase in the abundance of SGP-2 
transcript that we show here (i) is not associated with an 
opposite response of the ODC transcript comparable to 
that reported by us in several systems [3,5,6]; (ii) develops 
progressively and not transiently as in the case of andro- 
gen depletion [2]; and (iii) is not accompanied by the 
marked activation of apoptotic processes and organ in- 
volution that characterize the latter condition. These fea- 
tures suggest hat SGP-2 gene relaxation in the ventral 
prostate of the aging rat is part of a process which is 
different from that induced by androgen ablation. Thus, 
the diminution of the circulating levels of the latter 
hormones known to occur in the aging rat [23], can 
hardly be considered the cause of SGP-2 mRNA accu- 
mulation The possible role played by the progressive 
augmentation in the levels of estradiol occurring under 
the same conditions [23] is currently being investigated 
in our laboratory. 
Between 6 and 24 months of age, diminutions in ODC 
mRNA (Fig. 1) and activity (Fig. 2) occur that are simi- 
lar to those previously reported with AXC/SSh rats [24]. 
At variance with results obtained in the same laboratory 
[25], we found decreases and not increases in spermidine 
and spermine concentrations. Considering the role of 
polyamines in normal or pathological cell growth, we 
wonder whether these different responses to aging bear 
any connection to the proneness of AXC rat prostate to 
malignant transformation. 
The peak exhibited by ODC mRNA, ODC activity, 
putrescine and polyamine concentrations at 6 months 
indicates the occurrence, at around that age, of presently 
unknown physiologic event(s) requiring a transient en- 
hancement of the levels of these polycations. 
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